Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.45 USD | +1.88% | +4.89% | -46.13% |
05-08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
05-08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.13% | 648M | |
+31.47% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.21% | 239B | |
+10.02% | 210B | |
-7.32% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc., Q1 2019 Earnings Call, Nov 06, 2018